The Future of 3D Bio-Printing Market in North America in the forecast period (2019-2025) as predicted by Stratview Research

The report on 3D Bio-Printing Market in North America published by Stratview Research focusses on current trend insights and also predicts about the market condition and its future in the forecast period of 2019 – 2025

Click here to get a Free Sample of the report (additional insights inside):
https://www.stratviewresearch.com/Request-Sample/488/north-america-3D-bioprinting-market.html

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s demands, maps opportunities and hurdles in the 3D Bio-Printing Market in North America realities and future possibilities for the forecast period of 2019 to 2025. The report segments and analyzes the market in the most detailed and comprehensive manner to provide a panoramic view of the market.

Get a description of the report here:
https://www.stratviewresearch.com/488/north-america-3D-bioprinting-market.html

Report Segment
Bio-printers work on the same concept as 3D printers. The key difference between the two is that bio-printers deposit layers of biomaterial instead, which may include living cells, to build complex structures like blood vessels or skin tissue. To do this the required cells are taken from the patient and then cultivated until there are enough to create the bio-ink, which is then loaded into the printer (Source: Piotr Wnuk).
Bioprinting has been considered as one of the most promising technologies for fabricating artificial tissues and organs that could fast track and disrupt the conventional diagnostic tools and enhance the treatment of many different medical conditions. According to U Dmirci “Just as the printing press allowed massive amounts of information to be accessed at low cost for the first time in mankind’s history, so bio-printing could potentially provide a high-throughput and affordable way to assemble cells to make complex tissue constructs that are widely available to a very large number of researchers and scientists”
Demirci thinks that bio-printing is the process of using advanced additive manufacturing technologies to pattern biological materials, such as cells, biomaterials and biomolecules, for the fabrication of tissue-mimicking constructs. The technology requires biocompatible materials called bio-inks to act as the matrices for printed cells, which can then be grown in bioreactors to further develop and become functionally mature.
In terms of usage this report identifies dental implants and prosthetics to be major beneficiaries and offer more opportunities for new investors. In terms of technology, photo-polymerization shall have the largest market share in North America and shall grow up to USD 237.45 Million in 2025 (from USD 67.20 million in 2018).
This report also explores companies such as 3D Bioprinting Solutions Russia as one of the key companies for collaborations. The company recently announced the results of its study which produced the world’s first 3D printed transplantable organ, which will be used on a mouse. Another key collaborators could be Organovo in USA for the rest of the world market. For US Market, this company has just formed alliance with Samsara Science in 2018 and they are expected to work jointly towards this technology. Approximately $80 million from the federal government will be combined with more than $200 million in cost share to support the development of tissue and organ manufacturing capabilities. As part of continuing efforts to help revitalize American manufacturing and incentivize companies to invest in new technology development in the United States, ARMI will lead Biofab USA on behalf of the Department of Defense. Organovo is also advancing a preclinical program to develop its NovoTissues® liver therapeutic tissues for critical unmet medical needs, including certain life-threatening pediatric diseases. The Company has received orphan designation for its potential treatment of alpha-1-antitrypsin deficiency, its lead indication within the category of inborn errors of metabolism. Organovo is expected to change the shape of life science research and transforming medical care and a potential collaborator for new investors in the 3D bio-printing market.
Cellin, Bio3D, Organov are few companies that shall lead the market and competitors need to track the developments of these companies. The report also showcases key companies for collaborations and offers direct contact details of stakeholders. This is a must buy for venture capitals and bankers who are looking at future investments, along with HC IT companies, 3D printing companies looking for openings in bio-printing.

Market player:
The global life science/medical seals market is moderately consolidated with the top five players (Saint-Gobain S.A., Trelleborg AB, Freudenberg Group, IDEX Corporation and Parker Hannifin Corporation) capturing 39.1% share of the total market in 2018. These players are projected to remain dominant over the next five years as well. The USA is the manufacturing hub of the medical device industry with the presence of several OEMs, tier players, and raw material suppliers. North America and Europe (majorly Western Europe) are two biggest region in the medical device market with USA being the largest producer as well as the largest consumer of medical devices in the world.
All the top five players in the global life science/medical seals market, Saint-Gobain S.A., Trelleborg AB, Freudenberg Group, IDEX Corporation and Parker Hannifin Corporation; are either USA-based companies or based in Europe. There are modest number of players in the world manufacturing seals for the life science industry as it requires to meet the stringent FDA, USP, ISO as well as other standards (such as NSF) and approvals & certifications from OEMs, which is time-consuming and highly expensive and requires excellent technological capabilities.

Check the Table of Contents to browse through the report better:
https://www.stratviewresearch.com/toc/488/north-america-3D-bioprinting-market.html

Highlights of the Report:
Every ten minutes, someone is added to the national transplant waiting list in the American market. On an average 20-25 people die each day while waiting for a transplant surgery. The shortage of organ donors is not just confined to the US and scientists are turning to technology for help against this worldwide issue, In India and China the wait list is equally long. 3D Bio-printing market is expected to revolutionize the way humans are treated currently.
The North American market was worth USD 228.9 Million in 2018 and is expected to grow at a compound annual growth rate of 14.9% till 2025. It is expected that this market shall remain the largest till the next 5-6 years in terms of adoption and usage of 3D bio-printing.

Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
Based on the research, a proper report is crafted with the following key features:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

This release was published on openPR.